
Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

